ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Free Cash Flow

Annual FCF:

-$117.30M+$130.18M(+52.60%)
December 31, 2024

Summary

  • As of today, ARQT annual free cash flow is -$117.30 million, with the most recent change of +$130.18 million (+52.60%) on December 31, 2024.
  • During the last 3 years, ARQT annual free cash flow has risen by +$58.32 million (+33.21%).
  • ARQT annual free cash flow is now -3007.31% below its all-time high of -$3.77 million, reached on December 31, 2017.

Performance

ARQT Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Quarterly FCF:

-$9.75M+$21.23M(+68.52%)
June 30, 2025

Summary

  • As of today, ARQT quarterly free cash flow is -$9.75 million, with the most recent change of +$21.23 million (+68.52%) on June 30, 2025.
  • Over the past year, ARQT quarterly free cash flow has increased by +$35.37 million (+78.38%).
  • ARQT quarterly free cash flow is now -69.69% below its all-time high of -$5.75 million, reached on December 31, 2024.

Performance

ARQT Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

TTM FCF:

-$81.32M+$35.37M(+30.31%)
June 30, 2025

Summary

  • As of today, ARQT TTM free cash flow is -$81.32 million, with the most recent change of +$35.37 million (+30.31%) on June 30, 2025.
  • Over the past year, ARQT TTM free cash flow has increased by +$95.70 million (+54.06%).
  • ARQT TTM free cash flow is now -1292.96% below its all-time high of -$5.84 million, reached on December 31, 2018.

Performance

ARQT TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ARQT Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+52.6%+78.4%+54.1%
3Y3 Years+33.2%+84.3%+61.7%
5Y5 Years-172.0%+62.2%+18.1%

ARQT Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+58.3%-69.7%+87.9%at high+72.3%
5Y5-Year-172.0%+58.3%-69.7%+87.9%at high+72.3%
All-TimeAll-Time-3007.3%+58.3%-69.7%+87.9%-1293.0%+72.3%

ARQT Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$9.75M(+68.5%)
-$81.32M(+30.3%)
Mar 2025
-
-$30.99M(-439.1%)
-$116.69M(+0.5%)
Dec 2024
-$117.30M(+52.6%)
-$5.75M(+83.5%)
-$117.30M(+30.1%)
Sep 2024
-
-$34.83M(+22.8%)
-$167.80M(+5.2%)
Jun 2024
-
-$45.12M(-42.8%)
-$177.02M(+10.9%)
Mar 2024
-
-$31.60M(+43.8%)
-$198.66M(+19.7%)
Dec 2023
-$247.49M(+11.9%)
-$56.25M(-27.7%)
-$247.49M(+5.7%)
Sep 2023
-
-$44.05M(+34.0%)
-$262.42M(+10.6%)
Jun 2023
-
-$66.76M(+17.0%)
-$293.58M(-1.6%)
Mar 2023
-
-$80.43M(-13.0%)
-$288.88M(-8.8%)
Dec 2022
-$281.00M(-60.0%)
-$71.19M(+5.3%)
-$265.55M(-7.8%)
Sep 2022
-
-$75.20M(-21.2%)
-$246.33M(-16.1%)
Jun 2022
-
-$62.06M(-8.7%)
-$212.15M(-14.1%)
Mar 2022
-
-$57.10M(-9.9%)
-$185.96M(-5.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$175.62M(-54.9%)
-$51.97M(-26.7%)
-$175.62M(-12.6%)
Sep 2021
-
-$41.02M(-14.3%)
-$155.91M(-4.5%)
Jun 2021
-
-$35.87M(+23.3%)
-$149.16M(-7.3%)
Mar 2021
-
-$46.76M(-45.0%)
-$139.06M(-22.7%)
Dec 2020
-$113.35M(-162.8%)
-$32.25M(+5.9%)
-$113.35M(-14.2%)
Sep 2020
-
-$34.27M(-33.0%)
-$99.26M(-30.7%)
Jun 2020
-
-$25.78M(-22.5%)
-$75.93M(-30.2%)
Mar 2020
-
-$21.05M(-15.9%)
-$58.33M(-31.0%)
Dec 2019
-$43.13M(-206.2%)
-$18.16M(-65.8%)
-$44.53M(-38.2%)
Sep 2019
-
-$10.95M(-34.0%)
-$32.21M(-51.5%)
Jun 2019
-
-$8.17M(-12.6%)
-$21.27M(-62.4%)
Mar 2019
-
-$7.26M(-24.3%)
-$13.10M(-124.3%)
Dec 2018
-$14.09M(-273.1%)
-$5.84M
-$5.84M
Dec 2017
-$3.77M
-
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual free cash flow year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly free cash flow year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. TTM free cash flow year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual free cash flow?

The current annual free cash flow of ARQT is -$117.30M

What is the all-time high annual free cash flow for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual free cash flow is -$3.77M

What is Arcutis Biotherapeutics, Inc. annual free cash flow year-on-year change?

Over the past year, ARQT annual free cash flow has changed by +$130.18M (+52.60%)

What is Arcutis Biotherapeutics, Inc. quarterly free cash flow?

The current quarterly free cash flow of ARQT is -$9.75M

What is the all-time high quarterly free cash flow for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly free cash flow is -$5.75M

What is Arcutis Biotherapeutics, Inc. quarterly free cash flow year-on-year change?

Over the past year, ARQT quarterly free cash flow has changed by +$35.37M (+78.38%)

What is Arcutis Biotherapeutics, Inc. TTM free cash flow?

The current TTM free cash flow of ARQT is -$81.32M

What is the all-time high TTM free cash flow for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high TTM free cash flow is -$5.84M

What is Arcutis Biotherapeutics, Inc. TTM free cash flow year-on-year change?

Over the past year, ARQT TTM free cash flow has changed by +$95.70M (+54.06%)
On this page